A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
Pneumonia, Pneumocystis Carinii, HIV Infections
About this trial
This is an interventional treatment trial for Pneumonia, Pneumocystis Carinii focused on measuring AIDS-Related Opportunistic Infections, Pneumonia, Pneumocystis carinii, Pentamidine, Injections, Intravenous, Administration, Inhalation, Aerosols, Acquired Immunodeficiency Syndrome
Eligibility Criteria
Exclusion Criteria Co-existing Condition: Patients with the following are excluded: Previous history of adverse reaction to pentamidine. History of asthma. Pulmonary Kaposi's sarcoma. Patients with the following are excluded: Previous history of adverse reaction to pentamidine. History of asthma. Pulmonary Kaposi's sarcoma. Inability to understand the consent procedure. All patients hospitalized at Cedars-Sinai Medical Center with AIDS and possible Pneumocystis carinii pneumonia (PCP) will be eligible. Patients with HIV antibody or AIDS and a clinical presentation suggesting PCP are eligible.
Sites / Locations
- LyphoMed Inc